Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

Home

BAX

(BAX)

NYQ – Real Time Price. Currency in USD

15.97

-0.70 (-4.20%)

At close: Mar 27, 2026, 4:00 PM EDT

15.93

-0.04 (-0.25%)

After-hours: Mar 27, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Baxter to Host Annual Meeting of Stockholders in Virtual Format

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2026 Annual Meeting. Online access to the 2026 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2026 Annual Meeting in person. The virtual format provides a safe, c.

Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot

Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot

Largest Single Investment from a Corporate Foundation Aims to Strengthen Healthcare Resilience by Advancing Therapy Animal Visits in U.S. Healthcare Settings BELLEVUE, Wash. and DEERFIELD, Ill.

EU regulator warns of shortage in Baxter's cancer treatment until early 2027

EU regulator warns of shortage in Baxter's cancer treatment until early 2027

The European Union's medicines regulator said on Tuesday it expects Baxter International's cancer drugs containing ifosfamide will remain in shortage in the bloc well ‌into the first quarter of next year.

Baxter Announces CFO Transition

Baxter Announces CFO Transition

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade. Mr. Grade is leaving the company to prioritize family matters but will continue in an advisory capacity until April 30, 2026. Baxter has named Anita Zielinski as interim CFO, effective immediately, while the company conducts its search to fill the role. Ms. Zielinski joined Baxter in 2025 as senio.

Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Sticking With Baxter At The Lows

Sticking With Baxter At The Lows

Baxter International faces deep investor skepticism after disappointing guidance and management's decision to delay its Investor Day. Recent leadership changes and a flattened organizational structure are part of a turnaround effort, which is off to an admittedly bumpy start. But valuation is reasonable enough that BAX is a straight bet on the turnaround working.

Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript

Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript

Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript

Videos

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

President Trump demands drugmakers slash prices within 60 days